Public offerings are critical for biotech companies like Calidi Biotherapeutics to secure funding for research, development, and operations. This offering could signal confidence in the company's future prospects, potentially making it attractive to investors. However, the impact on the stock price will also depend on market perception and the company's ability to effectively utilize the raised funds.